- Home
- CWBC vs ARVN Comparison
CWBC vs ARVN Comparison
Compare CWBC & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWBC
- ARVN
- Stock Information
- Founded
- CWBC 1989
- ARVN 2015
- Country
- CWBC United States
- ARVN United States
- Employees
- CWBC N/A
- ARVN N/A
- Industry
- CWBC Major Banks
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- CWBC Finance
- ARVN Health Care
- Exchange
- CWBC Nasdaq
- ARVN Nasdaq
- Market Cap
- CWBC 398.6M
- ARVN 456.2M
- IPO Year
- CWBC 1996
- ARVN 2018
- Fundamental
- Price
- CWBC $21.25
- ARVN $7.62
- Analyst Decision
- CWBC Buy
- ARVN Buy
- Analyst Count
- CWBC 3
- ARVN 22
- Target Price
- CWBC $21.67
- ARVN $20.21
- AVG Volume (30 Days)
- CWBC 41.0K
- ARVN 1.4M
- Earning Date
- CWBC 10-23-2025
- ARVN 10-29-2025
- Dividend Yield
- CWBC 2.29%
- ARVN N/A
- EPS Growth
- CWBC 95.72
- ARVN N/A
- EPS
- CWBC 1.39
- ARVN N/A
- Revenue
- CWBC $132,829,000.00
- ARVN $372,800,000.00
- Revenue This Year
- CWBC $30.64
- ARVN $4.87
- Revenue Next Year
- CWBC $6.58
- ARVN N/A
- P/E Ratio
- CWBC $15.05
- ARVN N/A
- Revenue Growth
- CWBC 55.84
- ARVN 299.57
- 52 Week Low
- CWBC $15.57
- ARVN $5.90
- 52 Week High
- CWBC $22.89
- ARVN $29.61
- Technical
- Relative Strength Index (RSI)
- CWBC 60.87
- ARVN 50.66
- Support Level
- CWBC $20.90
- ARVN $7.58
- Resistance Level
- CWBC $21.30
- ARVN $8.23
- Average True Range (ATR)
- CWBC 0.30
- ARVN 0.38
- MACD
- CWBC -0.02
- ARVN 0.01
- Stochastic Oscillator
- CWBC 47.22
- ARVN 35.11
About CWBC Community West Bancshares
Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the Company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.